Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Medicina (Kaunas, Lithuania)|May 27, 2026
Holistic Management of Pulmonary Fibrosis: A Comprehensive ReviewInés Palacio, Fernanda Hernández-González, Jacobo Sellarés, et al.Medicina (Kaunas, Lithuania)|August 28, 2025
A Pragmatic Tele-Nursing Program Improves Satisfaction of Patients with Pulmonary Fibrosis and Their Caregivers-A Pilot StudyMireia Baiges, David Iglesias, Sara Persentili, et al.ERJ Open Research|October 26, 2022
Telemedicine home CPAP titration and follow-up in the COVID-19 scenarioJaume Bordas-Martinez, Neus Salord, Eva Fontanilles, et al.Medicine|August 10, 2022
Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot programJaume Bordas-Martinez, Lluís Matéu Gómez, David Cámara Menoyo, et al.ERJ Open Research|August 26, 2021
N3 hilar sampling decision in the staging of mediastinal lung cancerJaume Bordas-Martinez, Jose Luis Vercher-Conejero, Guillermo Rodriguez-González, et al.Respiratory Research|June 18, 2024
Treating sleep-disordered breathing of idiopathic pulmonary fibrosis patients with CPAP and nocturnal oxygen treatment. A pilot study : Sleep-disordered breathing treatment in IPFJaume Bordas-Martinez, Neus Salord, Vanesa Vicens-Zygmunt, et al.Multidisciplinary Respiratory Medicine|June 4, 2025
Viability of a new home program of forced spirometry with bronchodilator response measurement in the assessment of patients with asthmaHéctor Cabrerizo Carreño, Cristina Bellver Asperilla, Ana Maria Romero-Ortiz, et al.JHLT Open|March 27, 2025
Outcomes of lung transplantation in patients with telomere-related forms of progressive fibrosing interstitial lung disease pulmonary fibrosis: A systematic reviewJaume Bordas-Martinez, Jelle R Miedema, Bas J Mathot, et al.ERJ Open Research|February 27, 2024
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort studyEsteban Cano-Jiménez, Ana Villar Gómez, Eduardo Velez Segovia, et al.The European Respiratory Journal|March 28, 2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trialGuadalupe Bermudo-Peloche, Belén Del Rio, Vanesa Vicens-Zygmunt, et al.Pageof 2